PICR Director / Purdue University professor Andrew Mesecar (right) and graduate student Sydney Beechboard conduct research to develop treatments for hepatocellular carcinoma. Mesecar is leading a project that has received $50,000 from Purdue Innovates Incubator to further advance the research. (Purdue University photo/Charles Jischke)
PICR Director Andrew Mesecar is developing patented enzyme inhibitors as treatments for hepatocellular carcinoma, the most common type of liver #cancer. Purdue Innovates' Trask Innovation Fund is helping advance this breakthrough work. #CancerResearch #CancerScience #Oncology_Innovations #BeatCancer